Digestive / Research profile
06 / 13Retatrutide
Investigational triple receptor agonist
Investigational · not FDA-approved
What is Retatrutide?
Retatrutide is an investigational molecule being developed by Lilly. It is studied as a once-weekly injectable medication in controlled clinical trials, not as a general wellness supplement.
The important distinction
This is an educational reference, not a recommendation to purchase or use retatrutide. A research-compound label does not establish identity, regulatory approval or equivalence to the investigational medication. No human-use purchase link is provided in this profile.
Educational profile only. No purchase recommendation or human-use product link.
